> News
 > TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany
News
29/11/2022

TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. […]

Access the press release

Our news

News
14/05/2024
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
News
23/09/2024
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ
News
23/01/2024
Focus SoHO et Paquet Pharma
> READ
> See all news